Media-OutReach Newswire The global leader in rabies vaccines, the serum-free iterative rabies vaccine of AIM Vaccine has submitted a pre-application for marketing registration
Media-OutReach Newswire Phase III clinical data of AIM Vaccine iterative serum-free rabies vaccine reaches preset goals
Media-OutReach Newswire The bull market of innovative drug technology is booming, and the leading stock AIM Vaccine has erupted upward
Politics & Law Việt Nam receives 300,000 doses of Vero-Cell COVID-19 vaccine donated by China's defence ministry